Zacks Research Analysts Boost Earnings Estimates for COO

The Cooper Companies, Inc. (NASDAQ:COO - Free Report) - Equities research analysts at Zacks Research increased their Q3 2025 earnings estimates for Cooper Companies in a research report issued to clients and investors on Thursday, June 19th. Zacks Research analyst I. Bandyopadhyay now expects that the medical device company will earn $1.06 per share for the quarter, up from their prior forecast of $1.05. The consensus estimate for Cooper Companies' current full-year earnings is $3.98 per share. Zacks Research also issued estimates for Cooper Companies' Q4 2025 earnings at $1.11 EPS, FY2025 earnings at $4.05 EPS and Q4 2026 earnings at $1.21 EPS.

Other equities analysts have also recently issued reports about the company. Piper Sandler reissued an "overweight" rating and issued a $105.00 target price (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Robert W. Baird lowered their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a report on Friday, May 30th. Citigroup dropped their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Needham & Company LLC raised Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a research note on Tuesday, June 17th. Finally, Wells Fargo & Company reduced their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Trading Down 0.5%

Shares of Cooper Companies stock opened at $69.47 on Monday. Cooper Companies has a 52-week low of $65.00 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The firm has a market capitalization of $13.89 billion, a PE ratio of 33.72, a price-to-earnings-growth ratio of 1.69 and a beta of 0.98. The company's fifty day moving average price is $77.28 and its two-hundred day moving average price is $84.93.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same period last year, the business posted $0.85 EPS. The business's quarterly revenue was up 6.3% on a year-over-year basis.

Institutional Investors Weigh In On Cooper Companies

Several institutional investors have recently bought and sold shares of COO. Proficio Capital Partners LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $95,000. Steward Partners Investment Advisory LLC increased its position in Cooper Companies by 19.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company's stock worth $129,000 after acquiring an additional 226 shares during the period. Cetera Investment Advisers grew its position in Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock worth $2,211,000 after buying an additional 312 shares in the last quarter. CX Institutional bought a new stake in shares of Cooper Companies during the 1st quarter valued at $107,000. Finally, Jones Financial Companies Lllp grew its holdings in shares of Cooper Companies by 227.7% during the 4th quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company's stock worth $89,000 after purchasing an additional 674 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.